WORLD STEM CELLS & REGENERATIVE MEDICINE
Panelists: Positives amid setbacks in cell therapy, regenerative medicine space
By Nuala Moran
Wednesday, May 21, 2014
LONDON There are storm clouds on the horizon for cell therapy and regenerative medicine, with a number of trial failures in the past few weeks and the mounting problems in getting reimbursement for high-cost products that are edging to market, adding to the huge scientific and development challenges that the sector faces.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.